An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: A North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort

Journal of Clinical Oncology

Volumn 22, Issue 12, 2004, Pages 2469-2476

  Jatoi, Aminah ^a   Rowland, Kendrith ^a   Loprinzi, Charles L ^a   Sloan, Jeff A ^a   Dakhil, Shaker R ^a   MacDonald, Neil ^a   Gagnon, Bruno ^a   Novotny, Paul J ^a   Mailliard, James A ^a   Bushey, Teresita I L ^a   Nair, Suresh ^a   Christensen, Brad ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ICOSAPENTAENOIC ACID; MEGESTROL ACETATE; PLACEBO; APPETITE STIMULANT;

ADULT; ANOREXIA; APPETITE; ARTICLE; BODY WEIGHT; CACHEXIA; CALORIC INTAKE; CANCER PATIENT; CANCER RESEARCH; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DIET SUPPLEMENTATION; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; SAMPLE SIZE; SCORING SYSTEM; SURVIVAL RATE; WEIGHT GAIN; AGED; CANADA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; FEMALE; MALE; MIDDLE AGED; MULTICENTER STUDY; NEOPLASM; RANDOMIZED CONTROLLED TRIAL; WASTING SYNDROME;

AGED; APPETITE; APPETITE STIMULANTS; BODY WEIGHT; CANADA; DIETARY SUPPLEMENTS; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; MALE; MEGESTROL ACETATE; MIDDLE AGED; NEOPLASMS; QUALITY OF LIFE; SURVIVAL RATE; WASTING SYNDROME;

EID: 2942706075     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.06.024     Document Type: Article

References (26)

1. Rosenberg IH: Fish: Food to calm the heart. N Engl J Med 346:1102-1103, 2002
2. Emsley R, Myburgh C, Oosthuzuizen P, et al: Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia. Am J Psychiatry 159:1596-1598, 2002
3. Hu FB, Bronner L, Willett WC, et al: Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 287:1815-1821, 2002
4. Geerling BJ, Badart-Smook A, van Deursen C, et al: Nutritional supplementation with N-3 fatty acids and antioxidants in patients with Crohn's disease in remission: Effects of antioxidant status and fatty acid profile. Inflamm Bowel Dis 6:77-84, 2000
5. Walsh D, Donnelly S, Rybicki L: The symptoms of advanced cancer: Relationship to age, gender, and performance status in 1000 patients. Support Care Cancer 8:175-179, 2000
6. Wigmore SJ, Barber MD, Ross JA, et al: Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer 36:177-184, 2000
7. Barber MD, Ross JA, Voss AC, et al: The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 81:80-86, 1999
8. Gogos CA, Ginopoulos P, Salsa B, et al: Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: A randomized control trial. Cancer 82:395-102, 1998
9. Wigmore SJ, Fearon KCH, Maingay JP, et al: Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clin Sci 92:215-221, 1997
10. Smith HJ, Lorite MJ, Tisdale MJ: Effect of a cancer cachectic factor on protein synthesis/degradation in murine C2C12 myoblasts: Modulation by eicosapentaenoic acid. Cancer Res 59:5507-5513, 1999
11. Whitehouse AS, Smith HJ, Drake JL, et al: Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid. Cancer Res 61:3604-3609, 2001
12. Baracos VE, DeVivo C, Hoyle DH, et al: Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Am J Physiol 268:E996-E1006, 1995
13. Loprinzi CL, Ellison NM, Schaid DJ, et al: Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst 82:1127-1132, 1990
14. Loprinzi CL, Kugler JW, Sloan JA, et al: Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. J Clin Oncol 17:3299-3306, 1999
15. Jatoi A, Windschitl HE, Loprinzi CL, et al: Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: A North Central Cancer Treatment Group study. J Clin Oncol 20:567-573, 2002
16. Sloan JA, Loprinzi CL, Laurine JA, et al: A simple stratification factor prognostic for survival in advanced cancer: The good/bad/uncertain index. J Clin Oncol 19:3539-3546, 2001
17. Scott NW, McPherson GC, Ramsay CR, et al: The method of minimization for allocation to clinical trials: A review. Control Clin Trials 23:662-674, 2002
18. Valk EE, Hornstra G: Relationship between vitamin E requirement and polyunsaturated fatty acid intake in man: A review. Int J Vitam Nutr Res 70:31-42, 2000
19. Sloan JA, Loprinzi CL, Kuross SA, et al: Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol 16:3662-3673, 1998
20. Cella DF, von Roenn JH, Lloyd S, et al: The Bristol Myers anorexia/cachexia instrument: A brief assessment of patients' subjective response to treatment of anorexia/cachexia. Qual Life Res 4:221-231, 1995
21. Pocock SJ: Clinical Trials: A Practical Approach. New York, NY, John Wiley, 1983, p 200
22. Bridge PD, Sawilowsky SS: Increasing physicians' awareness of the impact of statistics on research outcomes: Comparative power of the test and Wilcoxon rank-sum test in small samples research. J Clin Epidemiol 52:229-235, 1999
23. Lachin JM: Statistical considerations in the intent-to-treat principle. Control Clin Trials 21:167-189, 2000
24. Fearon KCH, von Meyenfeldt MF, Moses AG, et al: Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: A randomised double blind trial. Gut 52:1479-1486, 2003
25. Bruera E, Strasser F, Palmer JL, et al: Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: A double-blind, placebo-controlled study. J Clin Oncol 21:129-134, 2003
26. Goldberg RM, Loprinzi CL, Mailliard JA, et al: Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial. J Clin Oncol 13:2856-2859, 1995